| The clinical utility of exome and genome sequencing across clinical indications: a systematic review S Shickh, C Mighton, E Uleryk, P Pechlivanoglou, Y Bombard Human genetics 140, 1403-1416, 2021 | 63 | 2021 |
| The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results Y Bombard, M Clausen, C Mighton, L Carlsson, S Casalino, E Glogowski, ... European Journal of Human Genetics 26 (7), 984-995, 2018 | 51 | 2018 |
| Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysis C Mighton, S Shickh, E Uleryk, P Pechlivanoglou, Y Bombard Genetics in Medicine 23 (1), 22-33, 2021 | 49 | 2021 |
| Variant classification changes over time in BRCA1 and BRCA2 C Mighton, GS Charames, M Wang, KR Zakoor, A Wong, S Shickh, ... Genetics in Medicine 21 (10), 2248-2254, 2019 | 49 | 2019 |
| Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial Y Bombard, M Clausen, S Shickh, C Mighton, S Casalino, THM Kim, ... Genetics in Medicine 22 (4), 727-735, 2020 | 43 | 2020 |
| Perinatal psychosis in mothers with a history of major depressive disorder CE Mighton, AJ Inglis, PB Carrion, CL Hippman, EM Morris, ... Archives of women's mental health 19, 253-258, 2016 | 29 | 2016 |
| The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care S Shickh, SA Rafferty, M Clausen, R Kodida, C Mighton, S Panchal, ... Genetics in Medicine 23 (6), 1086-1094, 2021 | 28 | 2021 |
| Development of patient “profiles” to tailor counseling for incidental genomic sequencing results C Mighton, L Carlsson, M Clausen, S Casalino, S Shickh, L McCuaig, ... European Journal of Human Genetics 27 (7), 1008-1017, 2019 | 26 | 2019 |
| Quality of life drives patients’ preferences for secondary findings from genomic sequencing C Mighton, L Carlsson, M Clausen, S Casalino, S Shickh, L McCuaig, ... European Journal of Human Genetics 28 (9), 1178-1186, 2020 | 24 | 2020 |
| Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial S Shickh, M Clausen, C Mighton, S Casalino, E Joshi, E Glogowski, ... BMJ open 8 (4), e021876, 2022 | 23 | 2022 |
| Data sharing to improve concordance in variant interpretation across laboratories: results from the Canadian Open Genetics Repository C Mighton, AC Smith, J Mayers, R Tomaszewski, S Taylor, S Hume, ... Journal of medical genetics 59 (6), 571-578, 2022 | 20 | 2022 |
| Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study S Shickh, MG Salazar, KR Zakoor, C Lázaro, J Gu, J Goltz, D Kleinman, ... Journal of medical genetics 58 (4), 275-283, 2021 | 20 | 2021 |
| Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery S Shickh, D Hirjikaka, M Clausen, R Kodida, C Mighton, E Reble, J Sam, ... BMJ open 12 (4), e060899, 2022 | 16 | 2022 |
| A second update on mapping the human genetic architecture of COVID-19 M Kanai, SJ Andrews, M Cordioli, C Stevens, BM Neale, M Daly, A Ganna, ... Nature 621 (7977), E7-E26, 2023 | 15 | 2023 |
| Effect of genetics clinical decision support tools on health-care providers’ decision making: a mixed-methods systematic review A Sebastian, JC Carroll, LE Oldfield, C Mighton, S Shickh, E Uleryk, ... Genetics in Medicine 23 (4), 593-602, 2021 | 15 | 2021 |
| Widening the lens of actionability: a qualitative study of primary care providers’ views and experiences of managing secondary genomic findings A Sebastian, JC Carroll, M Vanstone, M Clausen, R Kodida, E Reble, ... European Journal of Human Genetics 30 (5), 595-603, 2022 | 14 | 2022 |
| Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario J Lerner-Ellis, C Mighton, C Lazaro, N Watkins, V Di Gioacchino, A Wong, ... Journal of Cancer Research and Clinical Oncology 147, 871-879, 2021 | 14* | 2021 |
| Beyond medically actionable results: an analytical pipeline for decreasing the burden of returning all clinically significant secondary findings E Reble, M Gutierrez Salazar, KR Zakoor, S Khalouei, M Clausen, ... Human Genetics 140, 493-504, 2021 | 14 | 2021 |
| Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial S Shickh, M Clausen, C Mighton, MG Salazar, KR Zakoor, R Kodida, ... BMJ open 9 (10), e031092, 2019 | 13 | 2019 |
| Recontacting clinical genetics patients with reclassified results: equity and policy challenges Y Bombard, C Mighton European Journal of Human Genetics 27 (4), 505-506, 2019 | 13 | 2019 |
